Calcium Hydroxylapatite With CO2 Laser for Acne Scars in 2026: What Longer Follow-Up Must Show for People With Atrophic Acne Scars

Longer follow-up must show whether scar gains last after filler resorption and stay safe across scar types and skin tones. In 2026, Chen et al. tested calcium hydroxylapatite filler — a volume-adding gel with mineral microspheres — with CO2 laser for atrophic scars.

Atrophic scars are indented scars from collagen loss. This combination matters if you live with indented acne scars and consider procedures. Early improvement alone cannot guide that choice without durability and safety data.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Who This Combination Targets
How Volume Plus Resurfacing Works
What Early Improvement Looked Like
What About Approval and Skin Risks
What Clinics Should Measure Next

Who This Combination Targets

Atrophic scars make up 80-90% of acne scars after collagen loss, described in Goodman and Baron grading literature via clinical review. They divide into ice-pick, boxcar, and rolling types.

Clinicians grade severity with Goodman-Baron and ECCA scales. Use this checklist to see if the 2026 findings relate to you:.

past acne leaves indented scars
scar type is ice-pick, boxcar, or rolling
clinic grades severity with Goodman-Baron or ECCA

How Volume Plus Resurfacing Works

The Journal of Cosmetic Dermatology systematic review in 2025 explains the filler action in its review of calcium hydroxylapatite fillers. Radiesse-type filler gives immediate volume from the gel carrier. Microspheres then act as a scaffold and stimulate fibroblast collagen, elastin, and vasculature. The effect lasts about 9-18 months before resorption.

The MDPI Life systematic review in 2025 reports 30-70% appearance improvement with fractional CO2 alone. Rolling and superficial boxcar scars respond best. Pitted and ice-pick scars respond least. The pairing joins volume support with laser resurfacing in one plan.

What Early Improvement Looked Like

The Aesthetic Plastic Surgery 2026 randomized study by Chen et al. reported significant improvement in all atrophic subtypes with p less than 0.001 in the study report. Boxcar scars improved 1.13±0.42 points. Rolling scars improved 0.93±0.47 points.

The difference between subtypes was not significant. For readers, early benefit did not favor one subtype. Boxcar change looked numerically higher, but the gap could be chance. Subtype-specific proof still needs longer split results.

What About Approval and Skin Risks

The U.S. FDA label lists Radiesse approval for moderate-to-severe facial wrinkles and folds such as nasolabial folds and HIV facial lipoatrophy, plus hand rejuvenation, in the premarket approval label. Acne scars are not listed as an approved use.

The Lasers in Medical Science meta-analysis in 2026 flags higher post-inflammatory hyperpigmentation risk with fractional CO2 than with microneedling or Er:YAG in the meta-analysis. It also notes transient erythema, edema, crusting, and prolonged recovery. Risk runs higher in darker or Asian skin.

What Clinics Should Measure Next

The Annals of Dermatology dermal filler review in 2023 points follow-up toward validated scores, recurrence, and late events. Clinics should repeat Goodman-Baron or ECCA scores beyond 12-18 months.

They should check recurrence after filler resorption. They should track late pigmentation or scarring by scar subtype and Fitzpatrick type, with sun protection. Ask for this plan before you agree: Bring your scar subtype and Fitzpatrick type to the consult and ask how each visit will record them.

Goodman-Baron or ECCA scores beyond 12-18 months
photo and score checks for recurrence after filler fades
tracking for late pigmentation or scarring
results split by your scar subtype and Fitzpatrick type
sun-protection steps after laser